E

Editas Medicine

CRISPR-based gene editing therapeutics developer

Senior Medical Director - Clinical Development

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$345k - $375k

About the Job

Requirements

  • MD or MD/PhD with training in cardiovascular diseases, internal medicine, rare disease, or related fields.
  • At least 10 years of industry experience in clinical research and development, including leadership of early-stage cardiovascular disease and/or rare disease programs.
  • Demonstrated experience designing and executing global clinical trials; experience with gene-editing, gene therapy, or advanced modalities is a plus.
  • Hands-on experience establishing or overseeing clinical trials, including collaboration with local CROs, investigators, and hospital partners.
  • Willingness to travel to develop and oversee global clinical trials.
  • Strong understanding of clinical trial methodology, translational science, safety monitoring, and global regulatory pathways.
  • Ability to work effectively in matrixed teams and influence across scientific, operational, and business stakeholders.
  • Written and verbal communication skills, including experience presenting to investigators, regulators, and internal governance bodies.
  • Strategic and pragmatic approach, with the ability to thrive in a high-growth biotech environment.
  • Strong network of clinical investigators and scientific collaborators globally, enabling effective partnership-building and study execution.

Responsibilities

  • Lead the design, medical oversight, and operational execution of clinical development strategies for EDIT-401, emphasizing early development (FIH, Phase 1–2) and translational endpoints relevant to gene editing.
  • Serve as clinical program lead, providing day-to-day medical and scientific leadership to ensure high-quality clinical execution and data integrity.
  • Partner with R&D to integrate biomarker strategy, safety monitoring approaches such as immunogenicity and off-target assessments, and indication rationale.
  • Contribute to developing and refining clinical development plans and study protocols, ensuring alignment with global regulatory expectations.
  • Support preparation of clinical documents for regulatory submissions, including IND, CTA, NDA/BLA components, and study reports, focusing on medical content and scientific rationale.
  • Collaborate with regulatory affairs and region-specific experts to prepare for interactions with global regulatory agencies.
  • Work with Clinical Operations, Regulatory, Project Management, CMC, Analytical Sciences, and Commercial to ensure integrated planning and execution.
  • Partner with Research teams on indication selection, biomarker development, and advancing new pipeline programs.
  • Provide clinical leadership in cross-functional forums, risk assessments, data reviews, and stage-gate processes.
  • Cultivate networks with global investigators, KOLs, and patient advocacy groups.
  • Lead or support scientific advisory boards, investigator meetings, and data-review interactions.
  • Represent the company at scientific conferences and contribute to manuscripts, abstracts, and presentations.

Desired Qualifications

  • Experience with gene-editing, gene therapy, or advanced modalities.

About the Company

Editas Medicine

CRISPR-based gene editing therapeutics developer

Editas Medicine develops therapies using CRISPR gene-editing to treat serious diseases. The company advances a pipeline of genomic medicines by discovering, developing, manufacturing, and aiming to commercialize these gene-editing treatments. CRISPR allows scientists to modify DNA in cells to correct genetic defects, and Editas combines this approach with clinical development to bring potential medicines to patients. Unlike firms that focus on other biotechnologies, Editas emphasizes a full drug-development cycle centered on CRISPR-based genomic medicines and partnerships to expand its reach. The company’s goal is to deliver durable, transformative treatments that improve patient outcomes worldwide by moving candidates from discovery through trials to potential approval and commercialization.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Editas Medicine

See more jobs